Tenofovir Disoproxil Fumarate (DF) Versus Emtricitabine/Tenofovir DF Fixed-Dose in Subjects Resistant to Lamivudine

This study is ongoing, but not recruiting participants.

Study NCT00737568 Information provided by Gilead Sciences

First Received: August 15, 2008 Last Updated: January 5, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	August 2014
Estimated Primary Completion Date:	November 2010 (Final data collection date for primary outcome measure)